NeuroTrauma Sciences
PrivateCompany Overview
NeuroTrauma Sciences is a biopharmaceutical company that was focused on developing drugs for the treatment of brain and neurological injuries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biopharmaceuticalneuroprotectiontraumatic brain injuryTBIischemic strokeneurorestorationneurosteroidexosome therapyCNS injurydrug discoveryclinical stage biotechbiotech startupprodrug developmentneurological repairbiotech pipeline
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroTrauma Sciences Comparables
Compare NeuroTrauma Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astrocyte Pharmaceuticals Inc. | 86% | |
| NoNO Inc. | 81% | |
| Nyrada Inc | 79% | |
NeuroTrauma Sciences Funding Rounds
Historical fundraising activity
NeuroTrauma Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroTrauma Sciences's valuation, stock price, and market status.
See something wrong or outdated?